Publikationen ohne Peer Review

Artikel in Zeitschriften ohne Peer Review

  • S. Zandi, T. Lereuil, F. Freiberg, M. Pfau, I. Pfister, C. Gerhardt, A. Meyenberg, S. Michels, L. Kodjikian, J. Garweg

    Long-Term Intravitreal Dexamethasone Treatment in Eyes with Pretreated Chronic Diabetic Macular Edema

    1.10.2017, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 33(8):620-628. doi: 10.1089/jop.2017.0020
  • J. Garweg, M. Deiss, C. Gerhardt, L. Kodjikian, I. Pfister

    Real-Life Experience with Aflibercept and Ranibizumab in the Treatment of Newly Diagnosed Neovascular Age-Related Macular Degneration over 24 Months

    1.9.2017, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 33(7):567-572. doi: 10.1089/jop.2017.0031
  • J. Garweg, S. Zandi, I. Pfister, M. Skowronska, C. Gerhardt

    Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfolation syndrome and glaucoma

    10.8.2017, Public Library of Science, 12(8):e0182571. doi: 10.1371/journal.pone.0182571
  • R. Nourinia, S. Nakao, S. Zandi, S. Safi, A. Hafezi-Moghadam, H. Ahmadieh

    ROCK inhibitors for the treatment of ocular diseases

    9.8.2017, The British journal of ophthalmology, pii: bjophthalmol-2017-310378. doi: 10.1136/bjophthalmol-2017-310378
  • J. Garweg, S. Zandi, C. Gerhardt, I. Pfister

    Isoforms of TGF-beta in the aqueous humor of patients with pseudoexfolation syndrome and a possible association with the long-term stability of the capsular bag after cataract surgery.

    28.6.2017, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 255(9):1763-1769. doi: 10.1007/s00417-017-3724-8
  • S. Zandi, F. Weisskopf, J. Garweg, M. Imesch, I. Pfister, C. Prünte, F. Sutter, K. Hatz

    Pre-Existing RPE Atrophy and Defects in the External Limiting Membrane Predict Early Poor Visual Response to Ranibizumab in Neovascular Age-Related Macular Degeneration

    1.4.2017, Ophthalmic surgery, lasers & imaging: the official journal of the International Society for Imaging in the Eye, 48(4):326-332. doi: 10.3928/23258160-20170329-07
  • J. Garweg, H. Russ, I. Pfister

    Early Response to Ranibizumab Is Predictive of Treatment Demand after a Therapeutic Switch to Aflibercept

    2017, Ophthalmology, 1:210-216
  • J. Garweg, S. Niderprim, H. Russ, I. Pfister

    Comparison of Strategies of Treatment with Ranibizumab in Newly-Diagnosed Cases of Neovascular Age-Realated Macular Degeneration.

    1.12.2016, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 33:773-778
  • S. Zandi, C. Tappeiner, I. Pfister, A. Despont, R. Rieben, J. Garweg

    Vitreal Cytokine Profile Differences Between Eyes With Epiretinal Membranes or Macular Holes

    1.11.2016, Investigative ophthalmology & visual science, 57(14):6320-6326. doi: 10.1167/iovs.16-20657
  • J. Garweg, E. Baglivo, F. Freiberg, M. Pfau, I. Pfister, S. Michels, S. Zandi

    Response of Postoperative and Chronic Uveitic Cystoid Macular Edema to a Dexamethasone-Based Intravitreal Implant (Ozurdex)

    1.9.2016, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 32(7):442-50
  • J. Garweg, S. Zandi

    Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment

    1.7.2016, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 1256-65
  • J. Garweg

    Diabetische Retinopathie und Makulopathie nehmen zu

    24.3.2016, Ars Medici (Schweizer Zeitschrift für Hausarztmedizin), 106:268-271
  • J. Garweg

    Alterbedingte Makuladegeneration – Ursachen und Therapie

    1.3.2015, Dialog, Dialog38 4-7
  • S. Wenger, C. Luvet, J. Garweg

    Regionalanästhesie bei intraokularen Eingriffen

    2015, Klinische Monatsblätter für Augenheilkunde, 232: 367-371
  • M. Wallon, J. Garweg, M. Abrahamowicz, C. Cornu, S. Vinault, C. Quantin, C. Bonithon-Kopp, S. Picot, F. Peyron, C. Binquet

    Ophthalmic Outcomes of Congenital Toxoplasmosis

    17.2.2014, Pediatrics, 2014 133(3):e601-8
  • F. Körner, U. Körner-Stiefbold, J. Garweg

    Systemic corticosteroids reduce the risk of cellophane membranes after retinal detachment surgery: a prospective randomized placebo-controlled double-blind clinical trial

    21.1.2012, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, Volume 250, Number 7 (2012), 981-987, DOI: 10.1007/s00417-011-1919-y
  • C. Tappeiner, F. Flückiger, M. Böhnke, D. Goldblum, J. Garweg

    Effect of topical anesthetic agents and ethanol on corneoepithelial wound healing in an ex vivo whole-globe porcine model

    2012, Journal of cataract and refractive surgery, 0886-3350, doi:10.1016/j.jcrs.2011.09.043
  • C. Tappeiner, J. Garweg

    Retinal vascular occlusion after vitrectomy with retrobulbar anesthesia-observational case series and survey of literature

    1.12.2011, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 249(12):1831-5
  • F. Peyron, J. Garweg, M. Wallon, E. Descolux, M. Rolland, J. Barth

    Long-term Impact of Treated Congenital Toxoplasmosis on Quality of Life and Visual Performance

    1.7.2011, The Pediatric Infectious Disease Journal, Volume 30, Number 7, July 2011
  • J. Garweg, C. Tappeiner

    Differenzialdiagnose der infektiösen posterioren Uveitis

    2011, Klinische Monatsblätter für Augenheilkunde, 2011 228: 268-272